Why Science? | ICH S13 Oligonucleotide Therapeutics Nonclinical Safety

The ICH concept paper defines the aim of harmonising nonclinical testing for oligonucleotide-based therapeutics and complementing existing safety guidelines. It anticipated consultation and later adoption milestones. A milestone in a work plan is a forecast, so the current public document status must be checked separately before applying recommendations.

The detective work in s13 is an active harmonisation project separates sequence, chemistry and delivery. The ICH concept paper defines the aim of harmonising nonclinical testing for oligonucleotide-based therapeutics and complementing existing safety guidelines. It anticipated consultation and later adoption milestones. A milestone in a work plan is a forecast, so the current public document status must be checked separately before applying recommendations. Keep this boundary visible: S13 was not a public final ICH guideline in the sources checked on 27 October 2026.

A strong science note separates observation from interpretation. Trace s13 is an active harmonisation project across sequence, chemistry, delivery, tissue exposure, target biology and observed finding. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Next chapter

The concept covers modalities such as antisense oligonucleotides, small interfering RNAs and other therapeutic oligonucleotides while recognising differences in mechanism, chemistry and delivery. A conclusion for one platform cannot be copied automatically to another with a different backbone, conjugate, target or tissue distribution.

For the scope spans more than one oligonucleotide class, model relevance is endpoint specific. The concept covers modalities such as antisense oligonucleotides, small interfering RNAs and other therapeutic oligonucleotides while recognising differences in mechanism, chemistry and delivery. A conclusion for one platform cannot be copied automatically to another with a different backbone, conjugate, target or tissue distribution. Preserve this guardrail: A predicted off-target is a hypothesis, not proof of a harmful biological effect.

A strong science note separates observation from interpretation. Challenge species relevance, assay sensitivity, tissue expression and exposure behind the scope spans more than one oligonucleotide class. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Base sequence determines intended hybridisation, while backbone and sugar modifications influence stability, binding, distribution and protein interactions. Conjugates and nanoparticles can redirect exposure. Safety assessment records all of these features so a signal can be attributed to the right layer.

A trustworthy account of sequence and chemistry are separate design layers links prediction to tissue exposure and measured biology. Base sequence determines intended hybridisation, while backbone and sugar modifications influence stability, binding, distribution and protein interactions. Conjugates and nanoparticles can redirect exposure. Safety assessment records all of these features so a signal can be attributed to the right layer. Remember: A species can be useful for chemistry-related toxicity while remaining irrelevant to target pharmacology.

A strong science note separates observation from interpretation. Reconstruct sequence and chemistry are separate design layers using sequence version, search database, dose, sample time and pathology record. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Studies show binding, target modulation and downstream biological response in suitable systems. Potency, duration and tissue context help connect exposure to pharmacology. A model that lacks the human target sequence may still inform chemistry-related toxicity but cannot reproduce exaggerated target pharmacology.

The detective work in primary pharmacology confirms intended action separates sequence, chemistry and delivery. Studies show binding, target modulation and downstream biological response in suitable systems. Potency, duration and tissue context help connect exposure to pharmacology. A model that lacks the human target sequence may still inform chemistry-related toxicity but cannot reproduce exaggerated target pharmacology. Keep this boundary visible: Platform precedent supports comparison only when the relevant sequence-independent attributes and exposures match.

A strong science note separates observation from interpretation. Reassess primary pharmacology confirms intended action after a sequence, chemistry, conjugate, carrier, route or target change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

In silico searches can identify transcripts with partial sequence complementarity and prioritise plausible hybridisation-dependent off-targets. Predictions depend on genome annotation, transcript expression, binding rules and algorithm thresholds. Experimental follow-up is needed for candidates that are biologically plausible and safety relevant.

For bioinformatics screens potential off-target matches, model relevance is endpoint specific. In silico searches can identify transcripts with partial sequence complementarity and prioritise plausible hybridisation-dependent off-targets. Predictions depend on genome annotation, transcript expression, binding rules and algorithm thresholds. Experimental follow-up is needed for candidates that are biologically plausible and safety relevant. Preserve this guardrail: S13 was not a public final ICH guideline in the sources checked on 27 October 2026.

A strong science note separates observation from interpretation. Trace bioinformatics screens potential off-target matches across sequence, chemistry, delivery, tissue exposure, target biology and observed finding. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

A conventional toxicology species may not share the target sequence or target biology. Investigators compare complementarity, expression, pharmacological response, tissue uptake and metabolism. Sometimes a surrogate oligonucleotide or a translatable weight-of-evidence strategy is needed, but each alternative creates its own interpretive boundary.

A trustworthy account of species relevance depends on sequence and biology links prediction to tissue exposure and measured biology. A conventional toxicology species may not share the target sequence or target biology. Investigators compare complementarity, expression, pharmacological response, tissue uptake and metabolism. Sometimes a surrogate oligonucleotide or a translatable weight-of-evidence strategy is needed, but each alternative creates its own interpretive boundary. Remember: A predicted off-target is a hypothesis, not proof of a harmful biological effect.

A strong science note separates observation from interpretation. Challenge species relevance, assay sensitivity, tissue expression and exposure behind species relevance depends on sequence and biology. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Oligonucleotides may accumulate in liver, kidney or other tissues depending on chemistry, route and delivery. Tissue concentrations, persistence and cellular uptake help explain organ findings and determine whether recovery periods are long enough. Plasma exposure alone may not represent the relevant tissue burden.

The detective work in tissue distribution reveals where risk can occur separates sequence, chemistry and delivery. Oligonucleotides may accumulate in liver, kidney or other tissues depending on chemistry, route and delivery. Tissue concentrations, persistence and cellular uptake help explain organ findings and determine whether recovery periods are long enough. Plasma exposure alone may not represent the relevant tissue burden. Keep this boundary visible: A species can be useful for chemistry-related toxicity while remaining irrelevant to target pharmacology.

A strong science note separates observation from interpretation. Reconstruct tissue distribution reveals where risk can occur using sequence version, search database, dose, sample time and pathology record. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Nonclinical studies relate administered dose to plasma and tissue exposure, target engagement and adverse observations over time. Nonlinear uptake, saturation, long half-lives and repeated dosing can change accumulation. Sampling must capture the compartment and time scale relevant to the suspected mechanism.

For toxicokinetics connect dose, exposure and findings, model relevance is endpoint specific. Nonclinical studies relate administered dose to plasma and tissue exposure, target engagement and adverse observations over time. Nonlinear uptake, saturation, long half-lives and repeated dosing can change accumulation. Sampling must capture the compartment and time scale relevant to the suspected mechanism. Preserve this guardrail: Platform precedent supports comparison only when the relevant sequence-independent attributes and exposures match.

A strong science note separates observation from interpretation. Reassess toxicokinetics connect dose, exposure and findings after a sequence, chemistry, conjugate, carrier, route or target change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Sequence complementarity can reduce or alter unintended transcripts. A credible assessment combines computational prediction, expression in exposed tissues, measured transcript or protein change, dose-response and biological consequence. A predicted match alone is not an adverse effect, while a negative assay in an irrelevant cell type is not reassurance.

A trustworthy account of hybridisation-dependent off-targets need causal evidence links prediction to tissue exposure and measured biology. Sequence complementarity can reduce or alter unintended transcripts. A credible assessment combines computational prediction, expression in exposed tissues, measured transcript or protein change, dose-response and biological consequence. A predicted match alone is not an adverse effect, while a negative assay in an irrelevant cell type is not reassurance. Remember: S13 was not a public final ICH guideline in the sources checked on 27 October 2026.

A strong science note separates observation from interpretation. Trace hybridisation-dependent off-targets need causal evidence across sequence, chemistry, delivery, tissue exposure, target biology and observed finding. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Backbone charge, protein binding, metabolites or high tissue concentrations can contribute to inflammation, complement activation, thrombocytopenia, liver or kidney findings and other platform-linked effects. Prior class knowledge can focus monitoring, but a new sequence or delivery system can change the pattern.

The detective work in hybridisation-independent toxicity can follow chemistry separates sequence, chemistry and delivery. Backbone charge, protein binding, metabolites or high tissue concentrations can contribute to inflammation, complement activation, thrombocytopenia, liver or kidney findings and other platform-linked effects. Prior class knowledge can focus monitoring, but a new sequence or delivery system can change the pattern. Keep this boundary visible: A predicted off-target is a hypothesis, not proof of a harmful biological effect.

A strong science note separates observation from interpretation. Challenge species relevance, assay sensitivity, tissue expression and exposure behind hybridisation-independent toxicity can follow chemistry. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Nucleic-acid sensors may recognise sequence motifs, structure or delivery complexes and trigger cytokines or inflammatory pathways. Species differences can be substantial. Assays should use relevant cells and controls, distinguish desired immune pharmacology from toxicity and connect in vitro signals with in vivo exposure.

For innate immune activation is context dependent, model relevance is endpoint specific. Nucleic-acid sensors may recognise sequence motifs, structure or delivery complexes and trigger cytokines or inflammatory pathways. Species differences can be substantial. Assays should use relevant cells and controls, distinguish desired immune pharmacology from toxicity and connect in vitro signals with in vivo exposure. Preserve this guardrail: A species can be useful for chemistry-related toxicity while remaining irrelevant to target pharmacology.

A strong science note separates observation from interpretation. Reconstruct innate immune activation is context dependent using sequence version, search database, dose, sample time and pathology record. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Lipid nanoparticles, polymers, ligands or conjugates can change biodistribution, cellular entry and persistence. Safety assessment separates the oligonucleotide, carrier, linker and combined product where possible. A platform history supports reasoning only when composition, dose and exposure remain comparable.

A trustworthy account of delivery systems bring their own evidence needs links prediction to tissue exposure and measured biology. Lipid nanoparticles, polymers, ligands or conjugates can change biodistribution, cellular entry and persistence. Safety assessment separates the oligonucleotide, carrier, linker and combined product where possible. A platform history supports reasoning only when composition, dose and exposure remain comparable. Remember: Platform precedent supports comparison only when the relevant sequence-independent attributes and exposures match.

A strong science note separates observation from interpretation. Reassess delivery systems bring their own evidence needs after a sequence, chemistry, conjugate, carrier, route or target change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Standard small-molecule genotoxicity batteries may not always be scientifically appropriate for large, polyanionic oligonucleotides, yet particular chemistry, impurities, metabolites or mechanism can create a cause for concern. The assessment explains uptake, plausible interaction with DNA and the relevance of any selected assay rather than following a reflex checklist.

The detective work in genotoxicity testing is question driven separates sequence, chemistry and delivery. Standard small-molecule genotoxicity batteries may not always be scientifically appropriate for large, polyanionic oligonucleotides, yet particular chemistry, impurities, metabolites or mechanism can create a cause for concern. The assessment explains uptake, plausible interaction with DNA and the relevance of any selected assay rather than following a reflex checklist. Keep this boundary visible: S13 was not a public final ICH guideline in the sources checked on 27 October 2026.

A strong science note separates observation from interpretation. Trace genotoxicity testing is question driven across sequence, chemistry, delivery, tissue exposure, target biology and observed finding. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Target biology, tissue exposure, placental transfer, class experience, study findings and intended patient population inform whether and how reproductive studies are conducted. FDA’s current programme work highlights circumstances where existing evidence may be sufficient, but regional guidance and product-specific discussion govern decisions.

For reproductive and developmental risk uses weight of evidence, model relevance is endpoint specific. Target biology, tissue exposure, placental transfer, class experience, study findings and intended patient population inform whether and how reproductive studies are conducted. FDA’s current programme work highlights circumstances where existing evidence may be sufficient, but regional guidance and product-specific discussion govern decisions. Preserve this guardrail: A predicted off-target is a hypothesis, not proof of a harmful biological effect.

A strong science note separates observation from interpretation. Challenge species relevance, assay sensitivity, tissue expression and exposure behind reproductive and developmental risk uses weight of evidence. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Long tissue persistence can outlast plasma disappearance. Recovery groups and post-dose observation should be long enough to show whether findings resolve, remain stable or progress. A short clean recovery period cannot exclude delayed effects when exposure or pharmacology persists.

A trustworthy account of recovery and reversibility need enough time links prediction to tissue exposure and measured biology. Long tissue persistence can outlast plasma disappearance. Recovery groups and post-dose observation should be long enough to show whether findings resolve, remain stable or progress. A short clean recovery period cannot exclude delayed effects when exposure or pharmacology persists. Remember: A species can be useful for chemistry-related toxicity while remaining irrelevant to target pharmacology.

A strong science note separates observation from interpretation. Reconstruct recovery and reversibility need enough time using sequence version, search database, dose, sample time and pathology record. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Well-characterised chemistry and delivery platforms may provide relevant prior evidence on common toxicities, analytical methods and tissue distribution. The bridge should compare sequence-independent attributes and identify what the new target or sequence changes. Thoughtful reuse supports the 3Rs without converting precedent into an automatic waiver.

The detective work in platform knowledge can reduce redundant studies separates sequence, chemistry and delivery. Well-characterised chemistry and delivery platforms may provide relevant prior evidence on common toxicities, analytical methods and tissue distribution. The bridge should compare sequence-independent attributes and identify what the new target or sequence changes. Thoughtful reuse supports the 3Rs without converting precedent into an automatic waiver. Keep this boundary visible: Platform precedent supports comparison only when the relevant sequence-independent attributes and exposures match.

A strong science note separates observation from interpretation. Reassess platform knowledge can reduce redundant studies after a sequence, chemistry, conjugate, carrier, route or target change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

The record includes current guideline status, sequence and modifications, purity and impurities, conjugate or carrier, intended target, off-target search version, pharmacology, species relevance, dose and route, plasma and tissue exposure, immune assays, pathology, reversibility, reproductive rationale, platform bridge, deviations and uncertainty.

For a complete s13 receipt separates every causal layer, model relevance is endpoint specific. The record includes current guideline status, sequence and modifications, purity and impurities, conjugate or carrier, intended target, off-target search version, pharmacology, species relevance, dose and route, plasma and tissue exposure, immune assays, pathology, reversibility, reproductive rationale, platform bridge, deviations and uncertainty. Preserve this guardrail: S13 was not a public final ICH guideline in the sources checked on 27 October 2026.

A strong science note separates observation from interpretation. Trace a complete s13 receipt separates every causal layer across sequence, chemistry, delivery, tissue exposure, target biology and observed finding. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter